187 related articles for article (PubMed ID: 15526245)
1. Statin therapy increases vascular sensitivity to angiotensin II in hypercholesterolaemic patients.
Sim JS; Dick JB; Struthers AD
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):109-13. PubMed ID: 15526245
[TBL] [Abstract][Full Text] [Related]
2. Tonic levels of angiotensin II reduce tonic levels of vascular nitric oxide even in salt-replete man.
Sim JS; Farquharson C; Struthers AD
J Renin Angiotensin Aldosterone Syst; 2004 Jun; 5(2):84-8. PubMed ID: 15295720
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
Rehman A; Rahman AR; Rasool AH
J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
[TBL] [Abstract][Full Text] [Related]
4. The angiotensin II receptor antagonist valsartan inhibits endothelin 1-induced vasoconstriction in the skin microcirculation in humans in vivo: influence of the G-protein beta3 subunit (GNB3) C825T polymorphism.
Mitchell A; Rushentsova U; Siffert W; Philipp T; Wenzel RR
Clin Pharmacol Ther; 2006 Mar; 79(3):274-81. PubMed ID: 16513451
[TBL] [Abstract][Full Text] [Related]
5. Effects of cerivastatin on forearm vascular responses, blood pressure responsiveness and ambulatory blood pressure in type 2 diabetic men.
Tran D; Lowy A; Howes JB; Howes LG
Diabetes Obes Metab; 2005 May; 7(3):273-81. PubMed ID: 15811145
[TBL] [Abstract][Full Text] [Related]
6. Selective AT1 receptor antagonism enhances sympathetically mediated vasoconstriction in man.
Lyons D; Jackson SH; Swift CG
Clin Pharmacol Ther; 2007 Jan; 81(1):83-7. PubMed ID: 17186003
[TBL] [Abstract][Full Text] [Related]
7. The effects of candesartan on vascular responses to angiotensin II and norepinephrine in normal volunteers.
Tran D; Phoon S; Howes L
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):199-203. PubMed ID: 11881123
[TBL] [Abstract][Full Text] [Related]
8. Lisinopril improves endothelial function in chronic cigarette smokers.
Butler R; Morris AD; Struthers AD
Clin Sci (Lond); 2001 Jul; 101(1):53-8. PubMed ID: 11410114
[TBL] [Abstract][Full Text] [Related]
9. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.
Farnier M; Averna M; Missault L; Vaverkova H; Viigimaa M; Massaad R; Vandormael K; Johnson-Levonas AO; Brudi P
Int J Clin Pract; 2009 Apr; 63(4):547-59. PubMed ID: 19222610
[TBL] [Abstract][Full Text] [Related]
10. Effect of the non peptide angiotensin II antagonist, GR117289C on the vasoconstrictor actions of angiotensin II in the human forearm.
Lyons D; Webster J; Nixon A; Young MM; Smith J; Benjamin N
Br J Clin Pharmacol; 1997 Mar; 43(3):323-6. PubMed ID: 9088589
[TBL] [Abstract][Full Text] [Related]
11. Effects of colesevelam hydrochloride on low-density lipoprotein cholesterol and high-sensitivity C-reactive protein when added to statins in patients with hypercholesterolemia.
Bays HE; Davidson M; Jones MR; Abby SL
Am J Cardiol; 2006 Apr; 97(8):1198-205. PubMed ID: 16616026
[TBL] [Abstract][Full Text] [Related]
12. Forearm vasodilator response to angiotensin II in elderly women receiving candesartan: role of AT(2)- receptors.
Phoon S; Howes LG
J Renin Angiotensin Aldosterone Syst; 2002 Mar; 3(1):36-9. PubMed ID: 11984746
[TBL] [Abstract][Full Text] [Related]
13. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
[TBL] [Abstract][Full Text] [Related]
14. The effect of statins on angiotensin II-induced hemodynamic changes in young, mildly hypercholesterolemic men.
Fleischmann EH; John S; Delles C; Schneider MP; Schmidt BM; Schmieder RE
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1120-6. PubMed ID: 15607618
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
16. Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria.
Dogra GK; Watts GF; Chan DC; Stanton K
Diabet Med; 2005 Mar; 22(3):239-42. PubMed ID: 15717868
[TBL] [Abstract][Full Text] [Related]
17. Local angiotensin-converting enzyme inhibition blunts endothelin-1-induced increase in forearm vascular resistance.
Abernethy DR; Laurie N; Andrawis NS
Clin Pharmacol Ther; 1995 Sep; 58(3):328-34. PubMed ID: 7554707
[TBL] [Abstract][Full Text] [Related]
18. Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Voors AA; van Geel PP; Oosterga M; Buikema H; van Veldhuisen DJ; van Gilst WH
J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):130-4. PubMed ID: 15526248
[TBL] [Abstract][Full Text] [Related]
19. Effect of low-density lipoprotein cholesterol on angiotensin II sensitivity: a randomized trial with fluvastatin.
van der Linde NA; Sijbrands EJ; Boomsma F; van den Meiracker AH
Hypertension; 2006 Jun; 47(6):1125-30. PubMed ID: 16618834
[TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin on body composition and markers of cardiovascular disease in HIV-infected men--a randomized, placebo-controlled study.
Mallon PW; Miller J; Kovacic JC; Kent-Hughes J; Norris R; Samaras K; Feneley MP; Cooper DA; Carr A
AIDS; 2006 Apr; 20(7):1003-10. PubMed ID: 16603852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]